CHRISTINA DANIEL: Open Payments
NPI 1629625330 · FRANKLIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 12 payments from 6 companies in 2025. Trend: 2023 $112 · 2024 $492 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $133 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Grifols USA, LLC | 1 | $24 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: DUPIXENT, FASENRA, Gamunex-C, NEFFY, INVEGA SUSTENNA, Rhapsido.
Industry payments across TN — which companies pay providers there.
